FocalTherics priced an underwritten public offering of 8,425,000 American Depositary Shares at $4.75 each, for expected gross proceeds of about $40.0 million before discounts, commissions and expenses. Each ADS represents one ordinary share with a nominal value of €0.13, and all ADSs are being sold by the company. The offering is expected to close on Aug. 14, 2026, subject to customary conditions. Underwriters have a 30-day option to buy up to 1,263,750 additional ADSs, equivalent to 15% of the base offering, at the public offering price less underwriting discounts and commissions. TD Cowen and Mizuho are acting as joint book-running managers, with H.C. Wainwright & Co. and Lucid Capital Markets as co-managers. FocalTherics previously said net proceeds are intended for operating costs, capital expenditures and general corporate purposes, including working capital. The sale is being conducted under an SEC shelf registration statement on Form S-3 filed March 25, 2026, amended March 27, 2026, and declared effective March 31, 2026. The company also said no public offering of the ADSs will be made in Europe.